PHOENIX Birmingham, part of the PHOENIX Group and a European leader in pharmaceutical services, partnered with Kaizen Institute to strengthen productivity and operational consistency at its site.
Operating in a highly regulated and complex industry, the organization focused on building a strong operational foundation through Lean practices and structured daily management.
By implementing KAIZEN™ routines, performance tracking, and standardized work, PHOENIX Birmingham achieved efficiency gains while reinforcing stability, governance, and a culture of continuous improvement.
The operational challenges
Scaling operations in pharmaceutical distribution exposed critical gaps. Teams had limited visibility into real-time performance, operational flow was disrupted by supplier variability, and there were no structured routines to support systematic problem solving. Without dedicated spaces for cross-functional collaboration, improvement efforts remained reactive — addressing symptoms rather than root causes.
Building a continuous improvement engine
Daily routines that drive performance
PHOENIX Birmingham introduced Daily KAIZEN™ stand-ups, visual management boards, and Lean KPIs to make performance visible at every level. Teams could quickly identify deviations, align priorities, and act on issues before they escalated.
Connecting leadership to the shop floor
Mission Control — a structured weekly meeting — brought managers and leaders together to review performance, challenge metrics, and define clear improvement actions. This created a direct link between operational teams and leadership, accelerating decision-making and cross-functional problem solving.
Stabilizing operations and sustaining standards
The Water Spider role was introduced to stabilize material flow and reduce daily disruptions. Alongside this, 5S and 6S principles reinforced workplace organization, while standard work routines for team leaders ensured that improvements were embedded and sustained over time — delivering an 18% productivity increase and over €1.2M in tangible financial benefits within 12 months.
See more on Pharmaceuticals
Find out more about transformation in this sector
See more on Manufacturing Operations
Find out more about improving this business area
